Search research articles
Contact Us
Filters
Showing results (371-380 of 487) with videos related to
Page
of 49
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 16, 2014
Synergy between VEGF/VEGFR inhibitors and chemotherapy agents in the phase I clinic
Chad Tang, Kenneth Hess, Denis Leonardo F Jardim, et al.
Investigational New Drugs
|
October 20, 2017
Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer
Shumei Kato, Denis L Jardim, Faye M Johnson, et al.
Frontiers in Oncology
|
May 8, 2026
Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors
Antoine Italiano, Teresa García Manrique, Enrique Grande Pulido, et al.
Investigational New Drugs
|
April 28, 2021
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study
Kyaw Zin Thein, Sarina A Piha-Paul, Apostolia Tsimberidou, et al.
The Oncologist
|
March 30, 2021
Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials
Ryan W Huey, Goldy C George, Penny Phillips, et al.
The Lancet. Oncology
|
August 21, 2020
Dabrafenib plus trametinib in patients with BRAF<sup>V600E</sup>-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial
Vivek Subbiah, Ulrik Lassen, Elena Élez, et al.
Cancer Research
|
May 20, 2016
Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study
Jennifer J Wheler, Filip Janku, Aung Naing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2020
Phase I Study of Everolimus, Letrozole, and Trastuzumab in Patients with Hormone Receptor-positive Metastatic Breast Cancer or Other Solid Tumors
Alexej Ballhausen, Jennifer J Wheler, Daniel D Karp, et al.
Cancer Medicine
|
November 25, 2016
Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience
Zhijie Wang, Naiyi Shi, Aung Naing, et al.
Scientific Reports
|
October 18, 2016
Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies
Vivek Subbiah, Kenneth R Hess, Muhammad Rizwan Khawaja, et al.
Page
of 49
Search research articles
Search
Showing results (371-380 of 487) with videos related to
Sort By:
Page
of 49
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 16, 2014
Synergy between VEGF/VEGFR inhibitors and chemotherapy agents in the phase I clinic
Chad Tang, Kenneth Hess, Denis Leonardo F Jardim, et al.
Investigational New Drugs
|
October 20, 2017
Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer
Shumei Kato, Denis L Jardim, Faye M Johnson, et al.
Frontiers in Oncology
|
May 8, 2026
Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors
Antoine Italiano, Teresa García Manrique, Enrique Grande Pulido, et al.
Investigational New Drugs
|
April 28, 2021
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study
Kyaw Zin Thein, Sarina A Piha-Paul, Apostolia Tsimberidou, et al.
The Oncologist
|
March 30, 2021
Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials
Ryan W Huey, Goldy C George, Penny Phillips, et al.
The Lancet. Oncology
|
August 21, 2020
Dabrafenib plus trametinib in patients with BRAF<sup>V600E</sup>-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial
Vivek Subbiah, Ulrik Lassen, Elena Élez, et al.
Cancer Research
|
May 20, 2016
Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study
Jennifer J Wheler, Filip Janku, Aung Naing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2020
Phase I Study of Everolimus, Letrozole, and Trastuzumab in Patients with Hormone Receptor-positive Metastatic Breast Cancer or Other Solid Tumors
Alexej Ballhausen, Jennifer J Wheler, Daniel D Karp, et al.
Cancer Medicine
|
November 25, 2016
Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience
Zhijie Wang, Naiyi Shi, Aung Naing, et al.
Scientific Reports
|
October 18, 2016
Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies
Vivek Subbiah, Kenneth R Hess, Muhammad Rizwan Khawaja, et al.
Page
of 49